Research and Markets: Global Diabetes Mellitus - Type 1 Drug Pipeline Capsule - 2012 Update

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/9ssmhp/global_diabetes) has announced the addition of the "Global Diabetes Mellitus - Type 1 Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Diabetes Mellitus - Type 1 Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Diabetes Mellitus - Type 1 market. It covers active Diabetes Mellitus - Type 1 pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Topics Covered:

1. Diabetes Mellitus - Type 1 - Disease Overview

2. Diabetes Mellitus - Type 1 Pipeline Overview

3. Diabetes Mellitus - Type 1 Phase 3 Clinical Trial Pipeline Insights

4. Diabetes Mellitus - Type 1 Phase 2 Clinical Trial Pipeline Insights

5. Diabetes Mellitus - Type 1 Phase 1 Clinical Trial Pipeline Insights

6. Diabetes Mellitus - Type 1 Preclinical Research Pipeline Insights

7. Diabetes Mellitus - Type 1 Discovery Stage Pipeline Insights

8. Diabetes Mellitus - Type 1 Drug Development Activities - Geographic Landscape

8.1. Diabetes Mellitus - Type 1 R&D Activities in North America

8.2. Diabetes Mellitus - Type 1 R&D Activities in Europe

9. Diabetes Mellitus - Type 1 Pipeline - Licensing Activities

Table 1. Diabetes Mellitus - Type 1 Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Diabetes Mellitus - Type 1 Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Diabetes Mellitus - Type 1 Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Diabetes Mellitus - Type 1 Pipeline Molecules - Preclinical Research

Table 5. Diabetes Mellitus - Type 1 Pipeline Molecules - Drug Discovery

Table 6. Diabetes Mellitus - Type 1 R&D Activities by Geography

Table 7. Diabetes Mellitus - Type 1 Pipeline Molecules - North America

Table 8. Diabetes Mellitus - Type 1 Pipeline Molecules - Europe

Table 9. Diabetes Mellitus - Type 1 Pipeline - Licensing Activities

Figure 1. Diabetes Mellitus - Type 1 Pipeline Molecules by R&D Stage

Figure 2. Diabetes Mellitus - Type 1 R&D Activities by Geography

For more information visit http://www.researchandmarkets.com/research/9ssmhp/global_diabetes

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals